Publicaciones científicas sobre COVID-19 ¿La evidencia presentada es de alta calidad?
-
Published:2021-09-02
Issue:3
Volume:62
Page:189-191
-
ISSN:2477-9393
-
Container-title:Investigación Clínica
-
language:
-
Short-container-title:Invest Clin
Publisher
Universidad del Zulia
Reference7 articles.
1. 1. Glasziou PP. Waste in COVID-19 research. A deluge of poor quality research is sabotaging an effective evidence based response. BMJ 2020;369:m1847 doi: 10.1136/bmj.m1847.
2. 2. Ioannides JPA. Coronavirus disease 2019: The harms of exaggerated information and nonevidence- based measures. Eur J Clin Invest. 2020;50:e13222. https://doi.org/10.1111/ eci.13222.
3. 3. Palayew A, Norgaard O, Safreed-Harmon K, Andersen TH, Rasmussen LN, Lazarus JV. Pandemic publishing poses a new COVID-19 challenge. Nat Hum Behav. 2020 Jul;4(7):666-669. doi: 10.1038/s41562-020-0911-0.
4. 4. Alexander PE, Borg Debono V, Mammen MJ, Iorio A, Aryal K, Deng D, Brocard E, Alhazzani W. COVID-19 coronavirus research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine. J Clin Epidemiol 2020;123:120-126. https:// doi.org/10.1016/j.jclinepi.2020.04.016.
5. 5. Editorial (2020) Coronavirus drugs trials must get bigger and more collaborative. Nature 2020;581(7807):120. doi: 10.1038/d41586-020-01391-9.